Search results for "FAILURE"

showing 10 items of 1977 documents

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

2021

ABSTRACT Background Heart transplantation (HT) is the reference treatment for patients with terminal heart failure. In recent years there has been a progressive increase in HT procedures in patients who have a circulatory support (CS). Methods This is a retrospective single-center study of 293 consecutive patients who underwent HT from 2009 to 2018, analyzing the evolution of the 2 cohorts: patients with and without CS as a bridge to HT. Baseline and evolutionary clinical data collected following the usual follow-up protocol were recorded, including clinical events observed during the follow-up 1 year after the procedure. Results The subgroup of patients transplanted with CS showed a higher…

Heart transplantationMechanical ventilationHeart FailureTransplantationmedicine.medical_specialtyMultivariate analysisbusiness.industryIncidence (epidemiology)medicine.medical_treatmentOdds ratiomedicine.diseasePrognosisConfidence intervalHeart failureInternal medicineCirculatory systemmedicineCardiologyHeart TransplantationHumansSurgerybusinessFollow-Up StudiesRetrospective StudiesTransplantation proceedings
researchProduct

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: A single-center experience

2010

Liver transplantation (LT) is the only curative option for patients with familial amyloid polyneuropathy (FAP) at present. Twenty patients with FAP underwent LT between May 1998 and June 2007. Transthyretin mutations included predominantly the Val30Met mutation but also 10 other mutations. Seven patients received a pacemaker prior to LT, and because of impairment of mechanical cardiac function, 4 combined heart-liver transplants were performed, 1 simultaneously and 3 sequentially. The first patient, who underwent simultaneous transplantation, died. Seven patients died after LT, with 5 dying within the first year after transplantation. The causes of death were cardiac complications (4 patien…

Heart transplantationTransplantationmedicine.medical_specialtyHepatologybiologybusiness.industrymedicine.medical_treatmentRestrictive cardiomyopathyLiver transplantationmedicine.diseaseSingle CenterGastroenterologySurgeryTransplantationTransthyretinInternal medicineHeart failuremedicinebiology.proteinSurgerybusinessPolyneuropathyLiver Transplantation
researchProduct

Composite risk scores and depression as predictors of competing waiting-list outcomes: the Waiting for a New Heart Study

2010

We evaluated two composite risk scores, (Heart Failure Survival Score, HFSS; German Transplant Society Score, GTSS), and depression as predictors of mortality and competing waiting-list outcomes [high-urgency transplantation (HU-HTx), elective transplantation, delisting because of clinical improvement] in 318 heart transplant (HTx) candidates (18% women; aged 53 ± 11 years) from 17 hospitals and newly registered with Eurotransplant. Demographic variables and depression (Hospital Anxiety and Depression Scale, HADS) were assessed using questionnaires. Variables to compute HFSS and GTSS, age, medications, and outcomes were provided by Eurotransplant. At 12 months, 33 patients died, 83 received…

Heart transplantationTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentHospital Anxiety and Depression Scalemedicine.diseaseTransplantationWaiting listInternal medicineHeart failuremedicineProspective cohort studyPsychiatrybusinessRisk assessmentDepression (differential diagnoses)Transplant International
researchProduct

Psychological Characteristics and Social Integration of Patients with Ischemic and Non-Ischemic Heart Failure Newly Listed for Heart Transplantation:…

2009

It is not known whether psychosocial risk factors for coronary artery disease (CAD) are present in patients listed for heart transplantation (HTx). The aim of this study was to examine whether HTx candidates with ischemic heart failure (due to CAD) have an adverse psychological risk profile and reduced social integration compared to patients with non-ischemic etiology. In the multi-site study "Waiting for a New Heart", waiting-list-related stressors, depression, anxiety, trait-anger, anger-expression, dispositional coping, social integration, and social support were assessed in 318 newly registered HTx candidates (53.5 ± 11.4 years, 18% female, left ventricular ejection fraction <25%). Medi…

Heart transplantationmedicine.medical_specialtyEjection fractionbusiness.industrymedicine.medical_treatmentmedicine.diseaseCoronary artery diseaseSocial supportInternal medicineHeart failuremedicineEtiologyCardiologyAnxietymedicine.symptombusinessPsychosocialApplied PsychologyApplied Psychology: Health and Well-Being
researchProduct

Adefovir for lamivudine resistant HBV: More than meets the eye

2007

– In patients with LAM resistance and high levels of HBV-DNA, especially if HBeAg positive, it may be difficult to obtain a strong virological suppression with ADV. – Restrictive criteria are needed to define virological response (HBV-DNA < 10 3 copies/ml or 200 IU/ml). – Early finding of non-response or of suboptimal response after 9–12 months of ADV therapy suggests a high risk of emergence of ADV-resistant strains and should prompt a change of treatment strategy. In patients with cirrhosis, due to the risk of liver failure, treatment changes should be considered even earlier, at 3–6 months.

Hepatitis B virusmedicine.medical_specialtyCirrhosisHepatologybusiness.industryvirusesLiver failurevirus diseasesLamivudinemedicine.diseasemedicine.disease_causeGastroenterologyVirological responseInternal medicineImmunologyHBVmedicineAdefovirTreatment strategyIn patientbusinessmedicine.drugJournal of Hepatology
researchProduct

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

2017

International audience; The advent of safe and highly effective direct-acting antiviral agents (DAAs) has had huge implications for the hepatitis C virus (HCV) transplant field, and changed our management of both patients on the waiting list and those with HCV graft re-infection after liver transplantation (LT). When treating HCV infection before LT, HCV re-infection of the graft can be prevented in nearly all patients. In addition, some candidates show a remarkable clinical improvement and may be delisted. Alternatively, HCV infection can be treated post-LT either soon after the transplant, taking advantage of the removal of the infected native liver, or at the time of disease recurrence, …

Hepatitis C chronicDrugmedicine.medical_specialtyConsensusAntiviral agentmedicine.medical_treatmentHepatitis C virusmedia_common.quotation_subjectWaiting listDiseaseGuidelineLiver transplantationGuidelinesmedicine.disease_cause03 medical and health sciences0302 clinical medicineMED/12 - GASTROENTEROLOGIAMedicineHumansDrug InteractionsIntensive care medicinemedia_commonLiver transplant candidateLiver transplantationHepatologybusiness.industryWaiting listsLiver failure[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyRecurrent hepatitis CDirect Antiviral AgentHepatitis C3. Good healthSurgerychronicAntiviral agentsWaiting list030220 oncology & carcinogenesisInterferon030211 gastroenterology & hepatologyLiver transplant recipientInterferonsbusinessComplication
researchProduct

CD8 T-Cell Immunotherapy of Cytomegalovirus Disease in the Murine Model

2010

Publisher Summary Cytomegaloviruses (CMVs) are conditional pathogens that are strictly species specific and are usually well controlled in their respective mammalian hosts by the effector mechanisms of both innate and adaptive immunity. Human CMV (hCMV) is mostly acquired perinatally as well as in early childhood and is transmitted, for instance, through breast milk and saliva. Whilst the immune response in an immunocompetent host prevents an overt CMV disease and rapidly terminates the productive acute infection, viral genome is maintained in most tissues for the life span of the infected host in a state known as viral latency. Latency implies that infectious virions are no longer produced…

HepatitisAdrenalitisEffectormedicine.medical_treatmentBone marrow failureImmunotherapyBiologymedicine.diseaseAcquired immune systemVirologyImmune systemImmunologymedicineCytotoxic T cell
researchProduct

Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

2021

Key Points Question What genetic variants are associated with juvenile amyotrophic lateral sclerosis (ALS)? Findings In this family-based genetic study, exome sequencing was performed in 3 patients diagnosed with juvenile ALS and failure to thrive; this identified de novo variants in SPTLC1 (p.Ala20Ser in 2 patients and p.Ser331Tyr in 1 patient). Variants in SPTLC1 are a known cause of hereditary sensory and autonomic neuropathy, type 1A, and these data extend the phenotype associated with this gene. Meaning De novo variants in the SPTLC1 gene are associated with juvenile ALS, a fatal neurological disorder.

Hereditary sensory neuropathy; L-serine; Mutations; Deoxysphingolipids; AccumulationEnzyme complexJuvenile amyotrophic lateral sclerosisSerine C-Palmitoyltransferase/dk/atira/pure/subjectarea/asjc/2700/2728Whole Exome Sequencing0302 clinical medicineMedicineFamily historyAmyotrophic lateral sclerosisChildIndex caseExome sequencingOriginal Investigation0303 health sciencesNeurosciences and neurology3. Good healthChild PreschoolFailure to thriveFemalemedicine.symptomLife Sciences & BiomedicineL-SERINECommentsHumanAdultmedicine.medical_specialtyAdolescent; Adult; Amyotrophic Lateral Sclerosis; Child; Child Preschool; Female; Genetic Predisposition to Disease; Humans; Mutation; Serine C-Palmitoyltransferase; Whole Exome Sequencing; Young AdultAdolescentClinical NeurologyNO03 medical and health sciencesYoung AdultDEOXYSPHINGOLIPIDSInternal medicineExome SequencingOnline FirstHumansJuvenileGenetic Predisposition to DiseasePreschool030304 developmental biologyACCUMULATIONScience & TechnologySPTLC1business.industryMUTATIONSResearchAmyotrophic Lateral Sclerosis3112 Neurosciencesmedicine.diseaseHEREDITARY SENSORY NEUROPATHYjuvenileMutation3111 BiomedicineNeurology (clinical)Neurosciences & NeurologyALSgeneticbusiness030217 neurology & neurosurgeryAmyotrophic Lateral Sclerosi
researchProduct

2017

We analyze historical and longitudinal research focusing on industry decline. Our analysis suggests that the literature’s general reliance on a few meta-theoretical arguments has important conseque...

History060106 history of social sciencesMeta-analysis0502 economics and business05 social sciencesEconomicsBusiness Management and Accounting (miscellaneous)Business failure0601 history and archaeology06 humanities and the artsBusiness and International ManagementMarketing050203 business & managementBusiness History
researchProduct

Tackling Market Failure or Building a Cartel? Creation of an Investment Regulation System in Finnish Forest Industries

2015

Government intervention in the economy is often justified by the need to correct market failures. This study analyzes one case, the investments of Finnish forest industries, in which, in the late 1960s and early 1970s, both policy makers and the trade association representing the sector reasoned that intervention was particularly necessary because otherwise, the only substantial natural resource in the small country would be overexploited. In the long run, however, the growth of forest resources turned out to be higher, and the demand for wood lower, than expected. Furthermore, the most influential industrialists managed to “capture” the regulatory system and make it a component of their ne…

Historyforest industryRegulatory capture060106 history of social sciencesinvestment regulation systemMarket economy0502 economics and businessEconomicsta615market failure0601 history and archaeology050207 economicsFinlandTrade associationMarket failure05 social sciencesCartel06 humanities and the arts15. Life on landInvestment (macroeconomics)Natural resourceIntervention (law)Economic interventionism8. Economic growthBusiness Management and Accounting (miscellaneous)cartelsEnterprise &amp; Society
researchProduct